LY3143921 structure
|
Common Name | LY3143921 | ||
|---|---|---|---|---|
| CAS Number | 1627696-53-0 | Molecular Weight | 327.319 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H14FN5O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LY3143921LY3143921 (LY-3143921) is an orally available, potent, selective inhibitor of Cdc7 kinase inhibitor, inhibits CDC7/DBF4 I and pMCM2 (S53) with IC50 values of 3.3 nM and 290 nM, respectively. Solid Tumors Phase 1 Clinical |
| Name | LY3143921 |
|---|
| Description | LY3143921 (LY-3143921) is an orally available, potent, selective inhibitor of Cdc7 kinase inhibitor, inhibits CDC7/DBF4 I and pMCM2 (S53) with IC50 values of 3.3 nM and 290 nM, respectively. Solid Tumors Phase 1 Clinical |
|---|---|
| References | References View Related Products by Target Cyclin-dependent Kinase (CDK) Solid Tumors |
| Molecular Formula | C16H14FN5O2 |
|---|---|
| Molecular Weight | 327.319 |
| InChIKey | WSICFXBHDWUFRU-PKLMIRHRSA-N |
| SMILES | CC1(c2ncncc2F)NC(=O)c2cc(-c3cn[nH]c3)ccc21.O |